Phase 3 Papulopustular Rosacea Study

Summary

Phase 3 Papulopustular Rosacea Study is a clinical trial^[1].

Key Facts

• Phase 3 Papulopustular Rosacea Study is in the country of Canada^[2].
• Phase 3 Papulopustular Rosacea Study is in the country of United States^[3].
• Phase 3 Papulopustular Rosacea Study's instance of is recorded as clinical trial^[4].
• Phase 3 Papulopustular Rosacea Study's start time is recorded as +2011-12-31T00:00:00Z^[5].
• Phase 3 Papulopustular Rosacea Study's end time is recorded as +2013-08-31T00:00:00Z^[6].
• Phase 3 Papulopustular Rosacea Study's sponsor is recorded as Galderma^[7].
• Phase 3 Papulopustular Rosacea Study's main subject is recorded as rosacea^[8].
• Phase 3 Papulopustular Rosacea Study's number of participants is recorded as {'unit': '1', 'amount': '+688'}^[9].
• Phase 3 Papulopustular Rosacea Study's title is recorded as A Phase 3 Randomized, Double Blind, 12 Week Vehicle Controlled, Parallel Group Study Assessing the Efficacy and Safety of CD5024 1 % Cream Versus Vehicle Cream in Subjects With Papulopustular Rosacea, Followed by a 40 Week Investigator Blinded Extension Comparing the Long Term Safety of CD5024 1% Cream Versus Azelaic Acid 15 % Gel.^[10].
• Phase 3 Papulopustular Rosacea Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Phase 3 Papulopustular Rosacea Study's ClinicalTrials.gov ID is recorded as NCT01494467^[12].
• Phase 3 Papulopustular Rosacea Study's research intervention is recorded as azelaic acid^[13].
• Phase 3 Papulopustular Rosacea Study's clinical trial phase is recorded as phase III clinical trial^[14].
• Phase 3 Papulopustular Rosacea Study's research site is recorded as Somerset Skin Centre^[15].
• Phase 3 Papulopustular Rosacea Study's research site is recorded as University of California, San Francisco^[16].
• Phase 3 Papulopustular Rosacea Study's research site is recorded as Emory University^[17].
• Phase 3 Papulopustular Rosacea Study's research site is recorded as Arlington Dermatology^[18].
• Phase 3 Papulopustular Rosacea Study's research site is recorded as Northwestern University^[19].
• Phase 3 Papulopustular Rosacea Study's research site is recorded as Hamzavi Dermatology^[20].
• Phase 3 Papulopustular Rosacea Study's research site is recorded as PMG Research^[21].
• Phase 3 Papulopustular Rosacea Study's research site is recorded as Oregon Dermatology & Research Center^[22].
• Phase 3 Papulopustular Rosacea Study's research site is recorded as Dermatrials Research^[23].
• Phase 3 Papulopustular Rosacea Study's research site is recorded as Burke Pharmaceutical Research^[24].
• Phase 3 Papulopustular Rosacea Study's research site is recorded as Deaconess Clinic^[25].
• Phase 3 Papulopustular Rosacea Study's research site is recorded as Philadelphia Institute of Dermatology^[26].